BACKGROUND Patient-centered clinical pharmacy services are still poorly developed in Europe, despite their demonstrated advantages in North America and the UK. Reporting European pilot experiences is, therefore, important to assess the usefulness of clinical pharmacy services in this specific context. OBJECTIVE To report the results of the first implementation of Belgian clinical pharmacy ser...

Purpose: To explore the influence of pharmacist factors on prescription decisions of physicians. Methods: A survey of literature was carried out across online databases and 12 relevant articles were identified. The influence of pharmacist factors on physician prescription decisions was identified in the articles. A conceptual model for investigating pharmacist factors that influence physicians’...

Introduction In our original report, “Making Health Care Safer” 2001, Kaushal and Bates noted that over 770,000 people were harmed or died in hospitals annually from adverse drug events (ADE), with incidence rates in hospital-based studies ranging from 2 to 7 per 100 admissions. In the outpatient setting, as they also noted, one study on adults estimated the ADE incidence rate at 3 percent. The...

JCPH – Vol. 62, n 6 – novembre–décembre 2009 528 difficult to find, but they will soon be replaced by people with new skills, for example, running a logistic, production, or distribution system or serving as a clinical practitioner-leader, akin to the leaders among our physician and nursing colleagues. Pharmacist specialties and their corresponding training and credentialling will form the basi...

Two clinical cases illustrate near-fatal reactions to fire ant venom encountered by an infant playing in the backyard, and by a pharmacist working indoors in a hospital setting under a ceiling ventilation duct.

BACKGROUND At the time this study was undertaken, clinical pharmacy services at the authors' institution, a tertiary care teaching hospital, were largely reactive in nature, with patients and units receiving inconsistent coverage. OBJECTIVE To develop an evidence-based model of proactive practice and to evaluate the satisfaction of pharmacists and other stakeholders after restructuring of cli...

PURPOSE The purpose was to describe clinical pharmacist interventions across a range of critical care units (CCUs) throughout the United Kingdom, to identify CCU medication error rate and prescription optimization, and to identify the type and impact of each intervention in the prevention of harm and improvement of patient therapy. MATERIALS AND METHODS A prospective observational study was u...

Drug-drug interactions (DDIs) can lead to increased toxicity or reduction in therapeutic efficacy. This study was designed to assess the incidence of potential drug interactions (PDI) and rank their clinical value in post coronary care unit (Post-CCU) of a teaching hospital in Tehran, Iran. In this prospective study, three pharmacists with supervision of a clinical pharmacist actively gathered ...

Global healthcare expenditure is escalating at an unsustainable rate. Money spent on medicines and managing medication-related problems continues to grow. The high prevalence of medication errors and inappropriate prescribing is a major issue within healthcare systems, and can often contribute to adverse drug events, many of which are preventable. As a result, there is a huge opportunity for ph...

More than a decade ago, Hepler and Strand1,2 introduced the concept that the therapeutic relationship between pharmacist and patient was an integral component of pharmaceutical care. They saw pharmaceutical care as “a covenantal relationship between a patient and a pharmacist in which the pharmacist performs drug use control functions (with appropriate knowledge and skill) governed by the aware...